对我们的产品有疑问？ 我们将尽早回复
CPhI Japan Connect
DCAT Week
CPhI North America
CPhI Korea
CPhI Worldwide
CPhI China
Dr. Reddy’s Fosaprepitant API offerings
Apixaban API – ready-to-compress granules and finished dosage forms
Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies
EMA Nitrosamine Guidance – Deadline March 31, 2021
Colloidal Iron Complex Formulations – Understanding and Developing the Process
Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations
Best Supply Chain Team of the Year - Pharma- 2021
Dr. Reddy's Mirabegron API offering in both alpha and amorphous form
Palbociclib – how a novel process development approach provides IP advantages
Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021
